These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30197984)

  • 1. Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.
    Valdez-Ortiz R; Navarro-Reynoso F; Olvera-Soto MG; Martin-Alemañy G; Rodríguez-Matías A; Hernández-Arciniega CR; Cortes-Pérez M; Chávez-López E; García-Villalobos G; Hinojosa-Heredia H; Camacho-Aguirre AY; Valdez-Ortiz Á; Cantú-Quintanilla G; Gómez-Guerrero I; Reding A; Pérez-Navarro M; Obrador G; Correa-Rotter R
    Kidney Int Rep; 2018 Sep; 3(5):1171-1182. PubMed ID: 30197984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP).
    Jurkovitz CT; Li S; Norris KC; Saab G; Bomback AS; Whaley-Connell AT; McCullough PA;
    Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S24-32. PubMed ID: 23507267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.
    Agudelo-Botero M; González-Robledo MC; Reyes-Morales H; Giraldo-Rodríguez L; Rojas-Russell M; Mino-León D; Ocampo-Morales DI; Valdez-Ortiz R
    Int J Equity Health; 2020 Jun; 19(1):90. PubMed ID: 32513177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
    Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival among patients with kidney failure in Jalisco, Mexico.
    Garcia-Garcia G; Briseño-Rentería G; Luquín-Arellan VH; Gao Z; Gill J; Tonelli M
    J Am Soc Nephrol; 2007 Jun; 18(6):1922-7. PubMed ID: 17494884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk in patients with autosomal dominant polycystic kidney disease.
    Mladsi D; Zhou X; Mader G; Sanon M; Wang J; Barnett C; Willey C; Seliger S
    BMC Nephrol; 2024 Feb; 25(1):56. PubMed ID: 38365638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital outcomes of transcatheter aortic valve replacement in patients with chronic and end-stage renal disease: a nationwide database study.
    Lorente-Ros M; Das S; Malik A; Romeo FJ; Aguilar-Gallardo JS; Fakhoury M; Patel A
    BMC Cardiovasc Disord; 2024 Jan; 24(1):21. PubMed ID: 38172786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney disease in Paraguay.
    Santa Cruz F; Cabrera W; Barreto S; Mayor MM; Báez D
    Kidney Int Suppl; 2005 Aug; (97):S120-5. PubMed ID: 16014089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal replacement therapy in Latin American end-stage renal disease.
    Rosa-Diez G; Gonzalez-Bedat M; Pecoits-Filho R; Marinovich S; Fernandez S; Lugon J; Poblete-Badal H; Elgueta-Miranda S; Gomez R; Cerdas-Calderon M; Almaguer-Lopez M; Freire N; Leiva-Merino R; Rodriguez G; Luna-Guerra J; Bochicchio T; Garcia-Garcia G; Cano N; Iron N; Cuero C; Cuevas D; Tapia C; Cangiano J; Rodriguez S; Gonzalez H; Duro-Garcia V
    Clin Kidney J; 2014 Aug; 7(4):431-436. PubMed ID: 25349696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of renal replacement therapy and peritoneal dialysis in Mexico.
    Cueto-Manzano AM; Rojas-Campos E
    Perit Dial Int; 2007; 27(2):142-8. PubMed ID: 17299147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meeting Treatment Goals in Patients on Extramural Dialysis in Health Social Security in Mexico.
    Muñoz-Menjivar C; Reyes-Sánchez I; Aguilar-Martínez C; Rodríguez-Rodríguez A; Mendoza-Gómez JL; Guerrero-Soto J; Lizardi-Gómez LF; Venegas-Vera AV; Hernández-Rivera JCH; Ramos-Sánchez A; Paniagua R
    Blood Purif; 2021; 50(1):93-101. PubMed ID: 32604095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of payment source, referral site, and place of residence on outcomes after allogeneic transplantation in Mexico.
    Gómez-De León A; López-Mora YA; García-Zárate V; Varela-Constantino A; Villegas-De Leon SU; González-Leal XJ; Del Toro-Mijares R; Rodríguez-Zúñiga AC; Barrios-Ruiz JF; Mingura-Ledezma V; Colunga-Pedraza PR; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Tarín-Arzaga L; González-López EE; Gómez-Almaguer D
    World J Transplant; 2024 Jun; 14(2):91052. PubMed ID: 38947965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of renal replacement therapy and long-term risk of chronic kidney disease and death in intensive care patients with acute kidney injury.
    Christiansen S; Christensen S; Pedersen L; Gammelager H; Layton JB; Brookhart MA; Christiansen CF
    Crit Care; 2017 Dec; 21(1):326. PubMed ID: 29282093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ; Streja E; Sumida K; Soohoo M; Ravel VA; Gaipov A; Potukuchi PK; Thomas F; Rhee CM; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1428-1437. PubMed ID: 28679562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivals.
    Chen YC; Li CY; Tsai SJ; Chen YC
    World J Clin Cases; 2019 Jun; 7(11):1270-1281. PubMed ID: 31236391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in renal care in Jalisco, Mexico.
    Garcia-Garcia G; Renoirte-Lopez K; Marquez-Magaña I
    Semin Nephrol; 2010 Jan; 30(1):3-7. PubMed ID: 20116641
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.